Literature DB >> 12411233

Psychopharmacologic treatment of generalized anxiety disorder and the risk of major depression.

Renée D Goodwin1, Jack M Gorman.   

Abstract

OBJECTIVE: The authors sought to determine the association between treatment for generalized anxiety disorder and the risk of major depression among adults in the community.
METHOD: Data were drawn from the National Comorbidity Survey (N=8,098), a representative sample of the United States population age 15-54. Cox proportional hazards were used to determine the association between specific forms of treatment for generalized anxiety disorder and the risk of major depression.
RESULTS: Psychopharmacologic treatment of generalized anxiety disorder was associated with a significantly lower risk of major depression. There was no significant association between either having seen a mental health professional for generalized anxiety disorder or having been prescribed a medication for generalized anxiety disorder and the risk of depression.
CONCLUSIONS: These results suggest an association between treatment for generalized anxiety disorder and lower risk of depression, which appears specific to pharmacologic treatment. Future research that leads to a more precise delineation of the underlying mechanism of the observed association is needed to identify and develop effective strategies to prevent onset of depression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411233     DOI: 10.1176/appi.ajp.159.11.1935

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  8 in total

1.  Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys.

Authors:  R C Kessler; N A Sampson; P Berglund; M J Gruber; A Al-Hamzawi; L Andrade; B Bunting; K Demyttenaere; S Florescu; G de Girolamo; O Gureje; Y He; C Hu; Y Huang; E Karam; V Kovess-Masfety; S Lee; D Levinson; M E Medina Mora; J Moskalewicz; Y Nakamura; F Navarro-Mateu; M A Oakley Browne; M Piazza; J Posada-Villa; T Slade; M Ten Have; Y Torres; G Vilagut; M Xavier; Z Zarkov; V Shahly; M A Wilcox
Journal:  Epidemiol Psychiatr Sci       Date:  2015-02-27       Impact factor: 6.892

2.  Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.

Authors:  Jonathan R T Davidson; Douglas E Feltner; Ashish Dugar
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 3.  Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.

Authors:  Keming Gao; David V Sheehan; Joseph R Calabrese
Journal:  Expert Rev Neurother       Date:  2009-08       Impact factor: 4.618

4.  Psychomotor and anxiolytic effects of mexazolam in patients with generalised anxiety disorder.

Authors:  Luís Ferreira; Maria-Luísa Figueira; Alberto Bessa-Peixoto; António Marieiro; Rodolfo Albuquerque; Cristina Paz; Ana Cerqueira; Pedro Damião; Ana Dolgner; Jasper Dingemanse
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 5.  Pharmacotherapy of anxiety disorders: a critical review.

Authors:  Nastassja Koen; Dan J Stein
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

6.  Trends in anxiety among adults in the United States, 2008-2018: Rapid increases among young adults.

Authors:  Renee D Goodwin; Andrea H Weinberger; June H Kim; Melody Wu; Sandro Galea
Journal:  J Psychiatr Res       Date:  2020-08-21       Impact factor: 4.791

7.  Predicting the onset and persistence of episodes of depression in primary health care. The predictD-Spain study: methodology.

Authors:  Juan Angel Bellón; Berta Moreno-Küstner; Francisco Torres-González; Carmen Montón-Franco; María Josefa GildeGómez-Barragán; Marta Sánchez-Celaya; Miguel Angel Díaz-Barreiros; Catalina Vicens; Juan de Dios Luna; Jorge A Cervilla; Blanca Gutierrez; María Teresa Martínez-Cañavate; Bárbara Oliván-Blázquez; Ana Vázquez-Medrano; María Soledad Sánchez-Artiaga; Sebastia March; Emma Motrico; Victor Manuel Ruiz-García; Paulette Renée Brangier-Wainberg; María Del Mar Muñoz-García; Irwin Nazareth; Michael King
Journal:  BMC Public Health       Date:  2008-07-25       Impact factor: 3.295

Review 8.  Epidemiology of anxiety disorders: from surveys to nosology and back.

Authors:  Dan J Stein; Kate M Scott; Peter de Jonge; Ronald C Kessler
Journal:  Dialogues Clin Neurosci       Date:  2017-06       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.